Pharmaceuticals, Biopharma and Life Sciences
Splice Therapeutics invented, designs, and creates RNA trans-splicing molecules (RTMs) to correct inherited or acquired mutations that cause human disease. RTMs allow gene editing by invading the natural splicing of a chosen pre-messenger RNA gene target to repair or insert desired genetic coding sequence into the resulting mRNA.